TITLE

Optimal treatment for idiopathic pulmonary fibrosis

AUTHOR(S)
Maher, T. M.; Wells, A. U.; Williams, T. J.; Wilson, J. W.
PUB. DATE
December 2008
SOURCE
Thorax;Dec2008, Vol. 63 Issue 12, p1120
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the review of novel treatment and lung transplantation in pulmonary fibrosis by Williams and Wilson.
ACCESSION #
35783459

 

Related Articles

  • Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis. Behr, J�rgen; Uruga, Hironori; Hanada, Shigeo; Kishi, Kazuma; Izumi, Shinyu; Likura, Motoyasu; Hirano, Satoshi; Martinez, Fernando J.; Raghu, Ganesh // New England Journal of Medicine;8/30/2012, Vol. 367 Issue 9, p869 

    A letter to the editor is presented in response to the article "Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis" in the May 24, 2012 issue.

  • Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial α-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Nakamura, T.; Isaka, Y.; Tsujie, M.; Rupprecht, H.D.; Akagi, Y.; Ueda, N.; Imai, E.; Hori, M. // Gene Therapy;4/15/2002, Vol. 9 Issue 8, p495 

    Reports that the introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction rats. Myofibroblasts; Northern blot analysis; Therapeutic strategy for...

  • Inside Lab Invest.  // Laboratory Investigation (00236837);Aug2011, Vol. 91 Issue 8, p1120 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the sensitization of cholangiocarcinoma cells to chemotherapy through the inhibition of autophagy, the efficacy of hydrogen sulfide in the treatment of psoriasis, and the promotion of...

  • Correction: Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan.  // Annals of Internal Medicine;5/6/2014, Vol. 160 Issue 9, p658 

    A correction to the article "Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan" that was published in a 2013 issue is presented.

  • Updated International Guidelines for IPF.  // AARC Times;Oct2015, Vol. 39 Issue 10, p66 

    The article informs that the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society and the Latin American Thoracic Association have published updated guidelines on treating idiopathic pulmonary fibrosis (IPF).

  • Interferon Gamma-1b Therapy for Advanced Idiopathic Pulmonary Fibrosis. Kalra, Sanjay; Utz, James P.; Ryu, Jay H. // Mayo Clinic Proceedings;Sep2003, Vol. 78 Issue 9, p1082 

    Examines the treatment of advanced idiopathic pulmonary fibrosis/usual interstitial pneumonia with interferon gamma-1b. Duration of treatment; Baseline pulmonary function tests; Patient medical history; Patient survival.

  • Punk rocker's lung: pulmonary fibrosis in a drug snorting fire-eater. Buchanan, D.R.; Lamb, D.; Seaton, A. // British Medical Journal (Clinical Research Edition);12/19/1981, Vol. 283 Issue 6307, p1661 

    Reports a case of a patient with pulmonary fibrosis in a drug snorting fire-eater in Great Britain. Identification of bilateral small nodular and irregular infiltrates in the lungs; Application of a needle biopsy specimen; Cause of fibrosis.

  • Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials? Jo Corte, Tamera; Goh, Nicole S.; Glaspole, Ian N.; Zappala, Christopher J.; Hopkins, Peter M.; Wilsher, Margaret L. // Thorax;May2013, Vol. 68 Issue 5, p491 

    A letter to the editor is presented in response to the article "Hot of the breath: mortality as a primary end-point in idiopathic pulmonary fibrosis (IPF) treatment trials: the best is the enemy of the good" by A.U. Wells and colleagues in the 2012 issue.

  • Pulmonary fibrosis associated with hypersensitivity to gold salts. Geddes, D.M.; Brostoff, Jonathan // British Medical Journal;6/12/1976, Vol. 1 Issue 6023, p1444 

    Examines the association of pulmonary fibrosis with hypersensitivity to gold salts. Occurrence of pulmonary fibrosis during gold treatment; Correlation between lymphocyte transformation with adverse reaction to gold; Effects of gold treatment.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics